“We write to draw to your attention the important health implications of Budget 2007, specifically the allocations for the federal strategy on illicit drugs and the striking absence of any budgetary support for harm reduction measures.”
FEATURES Stephen Lewis and Legal Network slam UN-funded drug board Glenn Betteridge ends four years at the Legal Network Sex workers hold strategy meeting in Toronto European Court of Human Rights considers Legal Network submission MEDIA Review article and Smith trial result in bump in coverage IN BRIEF Subcommittee on Solicitation Laws gets a failing … Read more
“The new national anti-drug strategy announced in the federal budget ignores the impressive body of scientific evidence on the value of investing in harm reduction and alternatives to criminal prosecution for non-violent drug offences. The new strategy funds law enforcement, prevention and treatment programs — three of the four so-called “pillars” common in many drug … Read more
“[W]e write to encourage you to continue showing Canada’s commitment to address the global HIV/AIDS crisis when you participate in the G8 development and cooperation Ministers meeting on March 27 and 28 in Berlin, Germany. “Prior to the International AIDS Conference in Toronto last summer, GTAG developed a four-point action plan recommending steps CIDA and … Read more
People who are particularly vulnerable to HIV are in many countries the first to be targeted by counterterrorism and security measures, says Executive Director Joanne Csete in this commentary published in The Lancet on March 3, 2007.
Nearly one in three HIV infections outside Africa is among people who inject drugs. The International Narcotics Control Board (INCB) could and should be playing a key role in stopping this injection-driven HIV epidemic — but it’s not. Instead, the Board — a 13-person, ostensibly independent body that does not speak for the United Nations … Read more
Article in “The Power of Pills — Social, Ethical & Legal Issues in Drug Development, Marketing and Pricing” (Pluto Books, 2006) In May 2004, Canada became the first country to enact detailed legislation to allow compulsory licensing of patented pharmaceuticals so that lower-cost, generic versions could be exported to eligible developing countries lacking the industrial … Read more